Tumor Fragment Implantation
Tumor Fragment Implantation - Related Videos
02:43
Tumor Implantation and Injection of a Tumor Vaccine in a Mouse Model
0 Views •
2025
This video demonstrates a cell-based tumor vaccination assay. A mouse, intradermally injected with B16-F10 melanoma cells for tumor formation, is vaccinated with B16-F10 cells secreting Flt3L cytokine near the developed tumor. The secreted Flt3L from the vaccine promotes the maturation and proliferation of dendritic cells that then present tumor antigens to T cells in lymph nodes, triggering a targeted anti-tumor immune response.
10:52
Stereotactic Intracranial Implantation and In vivo Bioluminescent Imaging of Tumor Xenografts in a Mouse Model System of Glioblastoma Multiforme
0 Views •
Cited by 42 •
2012
We describe an integrated method for the precise, stereotactic implantation of human glioblastoma multiforme cells into the brains of nude mice and subsequent serial in vivo imaging to monitor growth and response to treatment of the resultant xenografts.
04:34
Generating Rabbit Liver Carcinoma Model: A Surgical Procedure to Implant Tumor Tissue in Left Lobe of Liver for Induction of Hepatocellular Carcinoma
0 Views •
2025
In this video, we demonstrate the surgical implantation of tumor tissue into a rabbit liver to induce hepatocellular carcinoma. The procedure helps establish a reliable animal model to study tumor behavior and development of locoregional treatments targeting cancers of the liver.
06:13
Electroeluting DNA Fragments
0 Views •
Cited by 8 •
2010
This procedure allows the purification of DNA fragments with high yield.
03:59
Orthotopic Homograft Tumor Transplantation: A Technique to Generate Pancreatic Tumor Mouse Models
0 Views •
2023
The video explains a stepwise surgical method for orthotopic implantation of a tumor fragment from a cancerous donor to the pancreas of a non-cancerous recipient mice for development of pancreatic cancer. Orthotopically implanted PDAC could recapture the tissue microenvironment of human pancreatic cancers than conventional subcutaneous (SC) models more accurately.
FAQs
Successful engraftment depends on the implanted cells surviving the surgical transfer, obtaining an adequate blood supply, and adapting to the recipient’s microenvironment. Immune rejection can also prevent establishment, which is why immunodeficient animals are often used. These factors determine whether the fragment develops into a stable in vivo model suitable for subsequent biological analysis.
Immunodeficient animals reduce the likelihood that the recipient’s immune system will reject the implanted tumor tissue. This creates a more favorable opportunity for the fragment to survive and establish within the host. As a result, researchers can examine tumor growth and interactions with surrounding tissues without immune rejection becoming the primary barrier to model formation.
Implanted fragments may preserve aspects of the original tumor’s cellular organization and heterogeneity, meaning the model can contain varied cell populations and structural features from the source tissue. Retaining these characteristics helps researchers study tumor behavior in a context that includes more of the original biological complexity than a simplified tumor-cell system might provide.
The host microenvironment contributes to tumor development by supplying surrounding stromal and vascular tissues with which tumor cells can communicate. These interactions can affect how the implanted tissue grows, invades nearby regions, or responds to treatment. Studying this communication allows biology researchers to examine tumor behavior as a relationship between malignant tissue and its surrounding host.
A typical workflow begins with obtaining pieces of tumor tissue and surgically placing them into a recipient organism. The implanted material must then survive, receive blood supply, and interact with the host environment to establish the model. Once the tissue has engrafted, researchers can evaluate tumor growth, invasion, metastasis, or responses to selected treatments.
Established models can support analysis of tumor growth, local invasion, metastasis, and treatment response. Because the tissue remains within a living host, researchers can also investigate communication between tumor cells and surrounding stromal or vascular tissues. These outcomes provide complementary information about tumor progression and therapeutic effects in an in vivo biological setting.
Tumor Fragment Implantation is useful when researchers need an in vivo platform for comparing how different therapies affect tumor tissue. Parallel implanted models can provide a basis for examining treatment response alongside tumor growth or progression. Preserved cellular organization and heterogeneity may also help comparisons reflect the complexity of the original tumor material.
The approach connects tumor-cell behavior with the biology of the surrounding organism. Rather than examining tumor tissue in isolation, researchers can study how malignant cells interact with stromal and vascular tissues while evaluating progression and treatment response. This makes the method relevant to biology research focused on tumor development, tissue interactions, and host-dependent disease behavior.